| Financial Year |
March 31 2023 |
| Monetary Funds |
77,125,762.73 |
| Held-for-trading Financial Assets |
5,019,285.41 |
| Notes Receivable |
-- |
| Accounts Receivable |
85,292,892.93 |
| Advances to Suppliers |
35,261,014.85 |
| Other Receivables |
65,021,247.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,270,416.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,244,113.01 |
| Total Current Assets |
286,235,420.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,499,659.20 |
| Investment Properties |
-- |
| Fixed Assetes |
54,901,784.46 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
272,497,780.07 |
| R&D expenses |
-- |
| Goodwill |
235,636,336.50 |
| Long-Term Deferred and Prepaid Expenses |
8,134,834.93 |
| Deferred Income Tax Assets |
24,122,298.05 |
| Other Non-Current Assets |
32,020,000.00 |
| Sub-Total of Non-Current Assets |
649,794,646.22 |
| Total Assets |
936,030,066.91 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
25,826,025.25 |
| Accounts Received In Advance |
766,642.99 |
| Employee Compensation Payable |
6,035,397.24 |
| Taxes Payable |
4,246,543.47 |
| Interest Payable |
-- |
| Dividend Payable |
2,161,123.31 |
| Other payables |
42,041,223.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,905,133.96 |
| Other Current Liabilities |
169,622.91 |
| Sub-Total of Current Liabilities |
84,906,776.05 |
| Long-term Loans |
1,566,190.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
23,438,122.81 |
| Special Payable |
-- |
| Estimatied Liabilities |
899,917,746.46 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
61,912.77 |
| Sub-Total of Non-Current Liabilities |
931,116,865.81 |
| Total Liabilities |
1,016,023,641.86 |
| Paid-In Capital(Or Share Stock) |
1,510,547,023.00 |
| Capital Surplus |
1,330,617,584.25 |
| Surplus Reserve |
55,127,713.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,977,566,058.19 |
| Minority Stockholder's Interest |
2,751,520.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-82,745,095.84 |
| Owner's Equity（Stockholder's Equity） |
-79,993,574.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
936,030,066.91 |
